Search results for: 'diseas virtualization market size'

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...

After experiencing a significant post-Covid slump, the webinars and virtual events market returned to moderate growth in 2024. Growing at 4.8 percent over the previous year, revenue in 2024 is estimated to reach $1.45 billion. As in-person event attendance surged to its highest level in more than four years, event vendors have realigned their sol...

For more than two decades, VMware has dominated the enterprise virtualization market. The company’s hypervisor is a leader for virtualizing enterprise, on-premises workloads. As businesses have migrated to the cloud, VMware has adapted to maintain its leadership by partnering with cloud hyperscalers to offer virtualized cloud solutions that offer...

This report is a thorough examination of the current and future face of therapy for neurodegenerative diseases, such as Alzheimer's and Parkinson's. It articulates important growth drivers (e.g., precision medicine, AI paradigm for diagnostics, and the transformational megatrends of aging populations) and barriers they will face (e.g., the nature o...

Virtual reality (VR) is an interactive three-dimensional (3D) environment that is computer generated. Immersion into VR is an individual’s perception of having a physical presence in the non-physical world or the virtual world. Technology advancement in in VR in the recent years has led to significant improvements in quality, reductions in overall ...

11 Jan 2021  |  North America  |  Market Research

Increasing Demand for Value-based Care and Acute Shortage of ICU Staff to Drive Growth of the US & EU-5 Virtual Critical Care Solutions Market, 2025

Future Growth Potential to Be Accelerated by Opportunities in Affordable, Easy-to-Deploy, and Scalable Solutions

Infographics

×

Coronavirus (COVID-19) has fuelled a demand for solutions that can help cater to large patient populations remotely. Further, the shortage of intensivists, as estimated by the COMPACCS trial, is expected to increase from 22% in 2020 to 35% by 2030. These, as well as changing reimbursement policies, are some of the key trends that will define the fu...

22 Aug 2024  |  Global  |  Technology Research

Pipeline Assessment for Cardiovascular Diseases

Advanced Drug Modalities Fuel Cardiovascular Therapeutics Future Growth Potential

Infographics

×

Globally, CVD is the leading cause of death, with resurgence in higher-income countries and higher prevalence in low- and middle-income countries. While there have been many advancements made to this indication using wearables and advanced diagnostics and devices, growth in therapeutics has been veiled. Traditional pharmacotherapy faces the drawbac...

The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique genetic profiles, disease subtypes, and distinct biomarke...

The fifth generation (5G) of wireless technology has arrived and is being rolled out globally. 5G is possible because of the contributions of previous generations of wireless communications and several disruptive technologies, each of which must be understood at least at a high level to paint a full picture of the industry. This study centers on op...